Skip to main content

Table 2 Outcome occurrences and proportion of outcomes by quartile

From: Association between serum urate levels and all-cause mortality, cardiovascular and renal outcomes among gout patients in Singapore

Outcomes

Mortality

AMI

Stroke

ESRF

Number of participants without outcome at baseline

2866

2728

2716

2806

Overall Occurrences (%)*

800 (27.9)

362 (13.3)

191 (7.0)

218 (7.8)

Median follow-up time, years [IQR]

6.72 [4.17, 9.66]

6.50 [3.93, 9.58]

6.58 [4.02, 9.63]

6.56 [4.00, 9.58]

Occurrences by Quartile (%)*

    

Q1 [108–400µmol/L]

191 (6.6)

88 (3.2)

49 (1.8)

34 (1.2)

Q2 [400–493µmol/L]

161 (5.6)

81 (3.0)

50 (1.8)

31 (1.1)

Q3 [493–580µmol/L]

186 (6.5)

87 (3.2)

43 (1.6)

51 (1.8)

Q4 [580–1250µmol/L]

262 (9.1)

106 (3.9)

49 (1.8)

102 (3.6)

  1. AMI, Acute Myocardial Infarction
  2. ESRF, End-Stage Renal Failure
  3. *Refers to the proportion of incident cases among patients at risk of the condition at baseline (patients with the condition of interest prior to study entry were excluded from each analysis, e.g. patients who had an AMI prior to study entry were excluded from the analyses for AMI occurrence